Edition:
United States

Cellect Biotechnology Ltd (APOP.OQ)

APOP.OQ on NASDAQ Stock Exchange Capital Market

1.12USD
2:21pm EST
Change (% chg)

$-0.02 (-1.75%)
Prev Close
$1.14
Open
$1.15
Day's High
$1.17
Day's Low
$1.05
Volume
60,125
Avg. Vol
25,630
52-wk High
$7.85
52-wk Low
$1.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.052
Jun '18 0.00 -0.046
Mar '18 0.00 -0.028
FY 2017 Dec '17 0.00 -0.028
Sep '17 0.00 -0.070
Jun '17 0.00 -0.042
Mar '17 0.00 -0.137
 
*Note: Units in Millions ofShekel
**Note: Units in Shekel

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. -- 147.79 49.87
P/E Low - Last 5 Yrs. -- 47.97 24.25
Beta 2.07 1.08 0.90
Price to Sales (TTM) -- 49.51 6.29
Price to Book (MRQ) 12.06 10.14 5.26
Price to Tangible Book (MRQ) 12.39 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions -- 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.16 12.76
Sales (TTM) vs TTM 1 Yr. Ago -- 48.79 5.84
Sales - 5 Yr. Growth Rate -- 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -8.79 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago -60.47 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate 35.30 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.25
Current Ratio (MRQ) 8.17 3.50 3.08
LT Debt to Equity (MRQ) 0.00 18.65 11.38
Total Debt to Equity (MRQ) 0.00 31.33 16.12
Interest Coverage (TTM) -345.79 -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.41 12.87
Operating Margin (TTM) -- -184.63 6.19
Operating Margin - 5 Yr. Avg. -- -126.89 8.31
Pre-Tax Margin (TTM) -- -175.33 7.15
Pre-Tax Margin - 5 Yr. Avg. -- -132.69 8.61
Net Profit Margin (TTM) -- -182.03 3.29
Net Profit Margin - 5 Yr. Avg. -- -137.08 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,654,547 842,388,263
Net Income/Employee (TTM) -- 562,105 99,841,601
Receivable Turnover (TTM) -- 6.23 5.71
Inventory Turnover (TTM) -- 1.89 3.47
Asset Turnover (TTM) 0.00 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -128.02 6.39 11.06
Return on Assets - 5 Yr. Avg. -46.89 5.47 12.20
Return on Investment (TTM) -144.94 8.92 14.45
Return on Investment - 5 Yr. Avg. -72.71 6.78 15.87
Return on Equity (TTM) -182.75 10.08 15.96
Return on Equity - 5 Yr. Avg. -76.69 8.32 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -23.06 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellect Biotechnology Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.